A new method for the titration of lymphocytic choriomeningitis viruses.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 4970514)

Published in Arch Gesamte Virusforsch on January 01, 1967

Authors

F Lehmann-Grube, R Hesse

Articles by these authors

(truncated to the top 100)

Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J Virol (1987) 2.72

Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J Immunol (1985) 1.86

Arenoviruses: proposed name for a newly defined virus group. J Virol (1970) 1.81

Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse. J Gen Virol (1976) 1.79

Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J (1995) 1.52

Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology (1983) 1.49

DNA probes for identification of clinically important Bacteroides species. J Clin Microbiol (1986) 1.47

Enumeration of single IFN-gamma-producing cells in mice during viral and bacterial infection. J Immunol (1989) 1.47

The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Eur J Immunol (1987) 1.46

Virus-induced delayed-type hypersensitivity reaction is sequentially mediated by CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A (1989) 1.43

Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Eur J Immunol (1989) 1.41

A persistent and inapparent infection of L cells with the virus of lymphocytic choriomeningitis. J Gen Virol (1969) 1.27

Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3. N Engl J Med (1974) 1.24

Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism. Immunology (1978) 1.24

A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera. J Gen Virol (1977) 1.21

Infectious lymphocytes in lymphocytic choriomeningitis virus carrier mice. J Gen Virol (1979) 1.21

The immune response of the mouse to lymphocytic choriomeningitis virus. II. Active suppression of cell-mediated immunity by infection with high virus doses. J Gen Virol (1982) 1.17

The localized hemolysis-in-gel method adapted to the detection of spleen cells releasing virus-specific antibodies. J Immunol (1970) 1.14

Virus-specific delayed-type hypersensitivity (DTH). Cells mediating lymphocytic choriomeningitis virus-specific DTH reaction in mice. J Immunol (1990) 1.12

Defective interfering particles in mice infected with lymphocytic choriomeningitis virus. Virology (1977) 1.12

Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J Immunol (1998) 1.09

Entry of antivirally active T lymphocytes into the thymus of virus-infected mice. J Immunol (1991) 1.07

Persistent infection of mice with the virus of lymphocytic choriomeningitis: virus-specific immunological tolerance. Infect Immun (1974) 1.06

A carrier state of lymphocytic choriomeningitis virus in L cell cultures. Nature (1967) 1.05

Persistent infection of the mouse with the virus of lymphocytic choriomeningitis. J Clin Pathol Suppl (R Coll Pathol) (1972) 1.04

The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection. J Immunol (1984) 1.03

Portraits of viruses: arenaviruses. Intervirology (1984) 1.01

Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J Immunol (1992) 1.01

Emergence of virus escape mutants after immunization with epitope vaccine. J Virol (1995) 1.01

The immune response of the mouse to lymphocytic choriomeningitis virus. I. Circulating antibodies. J Gen Virol (1979) 1.00

Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. Lab Invest (1994) 0.98

Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo. J Virol (1996) 0.98

Infection of cultivated mouse peritoneal macrophages with lymphocytic choriomeningitis virus. J Gen Virol (1978) 0.97

Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection. J Exp Med (1987) 0.96

Homologous interference of lymphocytic choriomeningitis virus: detection and measurement of interference focus-forming units. J Virol (1976) 0.95

Multiplication of lymphocytic choriomeningitis virus in cultivated foetal inbred mouse cells and in neonatally infected inbred carrier mice. J Gen Virol (1974) 0.95

Mechanism of recovery from acute virus infection. III. Subclass of T lymphocytes mediating clearance of lymphocytic choriomeningitis virus from the spleens of mice. Med Microbiol Immunol (1985) 0.93

CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J Immunol (1994) 0.93

Lymphocytic choriomeningitis of the mouse. IV. Depression of the allograft reaction. Med Microbiol Immunol (1972) 0.92

Evidence for cytotoxic T-lymphocyte-target cell interaction in brains of mice infected intracerebrally with lymphocytic choriomeningitis virus. Acta Neuropathol (1983) 0.91

The immune response of the mouse to lymphocytic choriomeningitis virus. III. Differences of numbers of cytotoxic T lymphocytes in spleens of mice of different strains. Cell Immunol (1983) 0.91

Lymphocytic Choriomeningitis virus. I. Concentration and purification of the infectious virus. J Virol (1975) 0.90

Serologic diagnosis of human infections with lymphocytic choriomeningitis virus: comparative evaluation of seven methods. J Med Virol (1979) 0.89

Mechanism of recovery from acute virus infection. IX. Clearance of lymphocytic choriomeningitis (LCM) virus from the feet of mice undergoing LCM virus-specific delayed-type hypersensitivity reaction. J Gen Virol (1989) 0.88

Biochemical composition of lymphocytic choriomeningitis virus interfering particles. J Gen Virol (1981) 0.88

Immunopathologic alterations of lymphatic tissues of mice infected with lymphocytic choriomeningitis virus. II. Pathogenetic mechanism. Lab Invest (1981) 0.87

Micromethod for the titration of lymphocytic choriomeningitis virus in cell cultures. J Gen Virol (1975) 0.86

Dose-response relationships of lymphocytic choriomeningitis viruses in mice and L cell tube cultures. J Hyg (Lond) (1969) 0.86

IFN-gamma production in tissues of mice during acute infection with lymphocytic choriomeningitis virus. J Immunol (1990) 0.85

Lymphocytic choriomeningitis in the mouse. 3. Comparative titrations of virus strains in inbred mice. Arch Gesamte Virusforsch (1969) 0.84

Numbers of cytolytic T lymphocytes (CTL) and CTL precursor cells in spleens of mice acutely infected with lymphocytic choriomeningitis virus. Med Microbiol Immunol (1986) 0.84

Immunopathologic alterations of lymphatic tissues of mice infected with lymphocytic choriomeningitis virus. I. Histopathologic findings. Lab Invest (1981) 0.84

Lymphocytic choriomeningitis virus. IX. Properties of the nucleocapsid. Virology (1986) 0.84

T lymphocyte-mediated antiviral immune responses in mice are diminished by treatment with monoclonal antibody directed against the interleukin-2 receptor. Eur J Immunol (1994) 0.84

[Epidemiology of HIV in blood donors in West Germany]. Dtsch Med Wochenschr (1988) 0.84

Lymphocytic choriomeningitis virus. X. Demonstration of nucleoprotein on the surface of infected cells. Virology (1988) 0.84

Mechanism of recovery from acute virus infection. II. Effect of treatment of mice with cyclosporin A on their ability to eliminate the lymphocytic choriomeningitis virus. Med Microbiol Immunol (1985) 0.83

Mode of replication of lymphocytic choriomeningitis virus in persistently infected cultivated mouse L cells. Virology (1990) 0.83

Host cell-dependent homologous interference in lymphocytic choriomeningitis virus infection. Virology (1988) 0.83

Mechanism of recovery from acute virus infection. IV. Questionable role of mononuclear phagocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J Immunol (1987) 0.83

Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis. Lab Invest (1995) 0.83

Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes. J Immunol (1996) 0.82

Age-dependent susceptibility of murine T lymphocytes to lymphocytic choriomeningitis virus. J Gen Virol (1983) 0.81

Lymphocytic choriomeningitis virus. V. Proposed structural arrangement of proteins in the virion. J Gen Virol (1983) 0.81

Lymphocytic choriomeningitis virus. III. Structural proteins of the virion. J Gen Virol (1983) 0.81

Infection of murine T lymphocytes with lymphocytic choriomeningitis virus: effect of age of mice on susceptibility. Z Naturforsch C (1981) 0.80

Effects of stress and exercise on plasma corticosterone, plasma cholesterol, and aortic cholesterol levels in rats. Psychosom Med (1983) 0.80

Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources. J Viral Hepat (2009) 0.80

[The metabolism of organ cultures of cornea in TC 199 with added dextran 500 or hydroxyethyl starch 450]. Klin Monbl Augenheilkd (1990) 0.80

LCM virus infection of cells in vitro. Bull World Health Organ (1975) 0.80

[New surface antigens on LCM virus-infected cells]. Zentralbl Bakteriol Orig A (1974) 0.79

Antiviral protective immunity induced by major histocompatibility complex class I molecule-restricted viral T-lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins. J Virol (1995) 0.79

Infectious lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. Z Naturforsch C (1978) 0.79

[Studies on the virus of lymphocytic choriomeningitis. I. Stabilization of the virus]. Arch Gesamte Virusforsch (1968) 0.79

Viral nucleoprotein can be demonstrated on the surface of lymphocytic choriomeningitis virus-infected cells. Med Microbiol Immunol (1986) 0.79

Lymphocytic choriomeningitis virus. VIII. Reciprocal formation of pseudotypes with vesicular stomatitis virus. Virology (1984) 0.79

[Immunological phenomena in LCM virus-infected mice]. Zentralbl Bakteriol Orig A (1974) 0.79

[LCM virus-specific antigens]. Zentralbl Bakteriol Orig A (1974) 0.78

Lymphocytic choriomeningitis virus. IV. Electron microscopic investigation of the virion. Arch Virol (1983) 0.78

Studies on the mechanism of lymphocytic choriomeningitis virus homologous interference. Med Microbiol Immunol (1986) 0.78

Evaluation of the risk of PRRSV transmission via ingestion of muscle from persistently infected pigs. Transbound Emerg Dis (2008) 0.78

[Murine lymphocytic choriomeningitis: pathology of the lymphatic tissue]. Zentralbl Bakteriol Orig A (1974) 0.78

Lymphocytic choriomeningitis virus. II. Characterization of extractable complement-fixing activity. Med Microbiol Immunol (1976) 0.78

Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma. Clin Ther (1987) 0.78

Phytohemagglutinin-induced DNA synthesis in blood lymphocytes from mice persistently infected with the virus of lymphocytic choriomeningitis. Brief report. Arch Gesamte Virusforsch (1971) 0.77

[Phenylalanine hydroxylase activity in heterozygote hereditary carriers of the phenylketonuria gene]. Acta Biol Med Ger (1977) 0.77

[Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)]. Blut (1981) 0.77

Lymphocytic choriomeningitis virus. VII. Structural alterations of the virion by treatment with proteolytic enzymes without loss of infectivity. J Gen Virol (1984) 0.77

Antiviral immune responses of fully allogeneic irradiation bone marrow mouse chimeras. J Immunol (1991) 0.77

Persistent infection of cultivated cells with lymphocytic choriomeningitis virus: regulation of virus replication. Brief report. Arch Virol (1983) 0.76

Letter: Norrie's disease. Am J Ophthalmol (1974) 0.76

[HIV study of German Red Cross blood banks in Germany and Berlin]. Beitr Infusionsther (1991) 0.75

Influenza viruses in cell cultures. 3. Propagation in calf kidney cells. Arch Gesamte Virusforsch (1965) 0.75

[Pathogenesis of virus diseases]. Monatsschr Kinderheilkd (1970) 0.75

Investigation of plasma protein adsorption on functionalized nanoparticles for application in apheresis. Artif Organs (1999) 0.75

[Clinical and morphological studies in the early stages of hemochromatosis]. Dtsch Z Verdau Stoffwechselkr (1968) 0.75

[Nil nocere. Rachitis prevention in the newborn period]. Munch Med Wochenschr (1967) 0.75

[HIV study of the German Red Cross of West Germany 1985-1989: prevalence/incidence and mode of infection, retrospective studies]. Beitr Infusionsther (1990) 0.75

Evaluating recombinant protein immunoblot assay and polymerase chain reaction for diagnosis of non-A, non-B hepatitis. J Infect Dis (1992) 0.75

[Pathological immune phenomena in virus diseases]. Med Klin (1970) 0.75